phf10 Antibody

What is PHF10 and why is it important in research?

PHF10, also known as BAF45a or XAP135, is a subunit of the neural progenitors-specific chromatin remodeling complex (npBAF) that plays an essential role in the proliferation of neural progenitors. During neural development, a critical switch occurs as neurons exit the cell cycle: npBAF complexes containing ACTL6A/BAF53A and PHF10/BAF45A are exchanged for homologous alternative subunits in neuron-specific complexes (nBAF). This transition is fundamental for proper neural development and differentiation . Research on PHF10 has significant implications for understanding mechanisms underlying conditions such as cancer, neurological disorders, and developmental abnormalities .

How do I select the appropriate PHF10 antibody for my experiment?

When selecting a PHF10 antibody, consider these key factors:

• Application compatibility: Verify the antibody has been validated for your specific application (WB, IHC, IF, IP, etc.)

• Species reactivity: Ensure the antibody recognizes PHF10 in your experimental model species (human, mouse, rat, etc.)

• Clonality: Choose between polyclonal (broader epitope recognition) or monoclonal (higher specificity) based on your experimental needs

• Immunogen: Check whether the antibody targets the specific region of PHF10 relevant to your study

For neural development studies, antibodies recognizing the full-length protein are preferable, while for chromatin studies, antibodies targeting PHD finger domains might be more appropriate .

How does PHF10 function in the chromatin remodeling process?

PHF10 functions as a critical component of the npBAF complex, which regulates gene expression through ATP-dependent chromatin remodeling. By altering nucleosome positioning and chromatin accessibility, PHF10 contributes to transcriptional regulation crucial for neural progenitor proliferation. As neural progenitors exit mitosis and differentiate into neurons, PHF10/BAF45A in npBAF complexes is exchanged for homologous alternative DPF1/BAF45B or DPF3/BAF45C subunits in neuron-specific complexes. This transition is essential for proper neural development and establishes the self-renewal/proliferative capacity of multipotent neural stem cells . The PHD fingers in PHF10 likely recognize specific histone modifications, facilitating targeted chromatin remodeling at specific genomic loci.

What are the optimal conditions for Western blotting with PHF10 antibodies?

For optimal Western blot detection of PHF10:

• Sample preparation: Prepare whole cell lysates using RIPA buffer supplemented with protease inhibitors

• Protein amount: Load 20-50 μg of total protein per lane

• Dilution optimization: Start with antibody dilutions of 1:500-1:2000 as recommended by manufacturers

• Detection system: Use appropriate secondary antibodies conjugated to HRP or fluorescent tags

• Expected band size: PHF10 exhibits a molecular weight of approximately 56 kDa

Optimization steps:

• Test multiple antibody concentrations if signal is weak or background is high

• Include positive controls (tissues or cell lines known to express PHF10)

• For reducing non-specific binding, increase blocking time or adjust detergent concentration in wash buffers

How should I optimize immunohistochemistry protocols for PHF10 detection?

For successful IHC detection of PHF10:

• Fixation: Use 4% paraformaldehyde or 10% neutral buffered formalin

• Antigen retrieval: Apply heat-induced epitope retrieval using citrate buffer (pH 6.0)

• Blocking: Block with 5-10% normal serum from the same species as the secondary antibody

• Primary antibody: Apply PHF10 antibody at dilutions between 1:20-1:200

• Incubation: Incubate overnight at 4°C for optimal binding

• Visualization: Use appropriate detection systems (DAB for brightfield, fluorescent secondaries for IF)

Critical optimization considerations:

• Test multiple antigen retrieval methods if initial results are suboptimal

• Include tissue sections known to express PHF10 as positive controls

• Use sections from PHF10-knockout models as negative controls when available

• For each new antibody, the titer must be optimized for your specific application

What cell types or tissues are most appropriate for studying PHF10 expression?

Based on its biological function, these specimens are most relevant for PHF10 studies:

• Neural progenitor cells: Highest relevance as PHF10 is essential for their proliferation

• Developing neural tissues: Embryonic and early postnatal brain samples

• Stem cell populations: Various multipotent progenitor populations

• Cancer cell lines: Particularly those with dysregulated chromatin remodeling

For developmental studies, consider time-course experiments capturing neural progenitor to neuron transition, when the switch from PHF10-containing npBAF to neuron-specific nBAF complexes occurs . This transition is critical for understanding the role of PHF10 in neural development and can be effectively monitored using appropriate antibodies against PHF10 and other BAF complex components.

How can I perform co-immunoprecipitation to study PHF10 interactions with other BAF complex components?

For effective co-IP of PHF10 and BAF complex components:

• Cell preparation: Use neural progenitor cells or relevant cell lines expressing PHF10

• Lysis buffer: Employ gentle lysis conditions (150mM NaCl, 20mM Tris pH 7.5, 0.5% NP-40) with protease inhibitors

• Pre-clearing: Pre-clear lysate with protein A/G beads to reduce non-specific binding

• Antibody selection: Use PCRP-PHF10-2A10 or similar monoclonal antibodies validated for IP

• Incubation: Rotate overnight at 4°C with antibody

• Washing: Perform 4-5 gentle washes to remove non-specific interactions

• Analysis: Detect associated proteins by Western blot using antibodies against other BAF complex components

For detecting dynamic changes in complex composition:

• Compare IPs from neural progenitors versus differentiated neurons

• Include stringency controls using varying salt concentrations to distinguish strong from weak interactions

• Consider crosslinking approaches for capturing transient interactions

What approaches can resolve inconsistent or weak PHF10 antibody signals?

When troubleshooting weak or inconsistent PHF10 antibody signals:

• Sample preparation issues:

  • Ensure complete lysis and denaturation for Western blots

  • Verify protein concentration is sufficient (50-100μg total protein)

  • Check if proteolytic degradation is occurring by adding fresh protease inhibitors

• Antibody-specific factors:

  • Test alternative antibodies targeting different epitopes

  • Optimize antibody concentration through titration experiments

  • Verify storage conditions have not compromised antibody activity

• Application-specific optimizations:

  • For WB: Test different blocking agents (BSA vs. milk) and extend blocking time

  • For IHC/IF: Evaluate multiple fixatives and antigen retrieval methods

  • For all applications: Extend primary antibody incubation time or adjust temperature

• Expression level factors:

  • Verify PHF10 expression in your model system through qPCR

  • Use positive control samples known to express PHF10

  • Consider concentrating the protein through immunoprecipitation before detection

How can ChIP-seq be optimized when using PHF10 antibodies?

For successful ChIP-seq with PHF10 antibodies:

• Crosslinking optimization: Test different formaldehyde concentrations (0.5-2%) and incubation times

• Chromatin fragmentation: Optimize sonication conditions to achieve 200-500bp fragments

• Antibody selection: Use antibodies specifically validated for ChIP applications

• IP conditions: Incubate chromatin with 3-5μg of PHF10 antibody overnight at 4°C

• Washing stringency: Perform high-stringency washes to reduce background

• Controls: Include IgG negative controls and input DNA controls

Critical considerations:

• Perform antibody validation by Western blot prior to ChIP experiments

• Evaluate enrichment of known target regions by qPCR before sequencing

• Consider dual crosslinking with DSG (disuccinimidyl glutarate) followed by formaldehyde for improved chromatin-protein complex preservation

• For early developmental studies, optimize cell number requirements since material may be limited

How should I interpret changes in PHF10 expression during neuronal differentiation?

When analyzing PHF10 expression changes during neuronal differentiation:

• Expected pattern: PHF10 expression should decrease during the transition from neural progenitors to post-mitotic neurons

• Timing analysis: Follow the expression kinetics alongside markers of neural progenitors and mature neurons

• Localization changes: Track potential changes in subcellular localization using immunofluorescence

• Complex composition: Correlate PHF10 decrease with concurrent increase in DPF1/BAF45B or DPF3/BAF45C expression

Interpretation guidelines:

How can I resolve contradictory results between different PHF10 antibodies?

When facing contradictory results between different PHF10 antibodies:

• Epitope mapping: Determine which regions of PHF10 are recognized by each antibody

• Isoform specificity: Verify whether antibodies detect all PHF10 isoforms or are isoform-specific

• Validation approach:

  • Perform siRNA knockdown or CRISPR knockout of PHF10 to validate specificity

  • Use recombinant PHF10 protein as a positive control

  • Test antibodies in parallel on identical samples

• Resolution strategies:

  • For functionally important findings, confirm with at least two independent antibodies

  • Consider post-translational modifications that might affect epitope recognition

  • Supplement antibody-based methods with transcript analysis or mass spectrometry

What are the implications of PHF10 research for understanding neurological disorders?

PHF10 research has significant implications for neurological disorders due to its role in neural development:

• Neurodevelopmental disorders:

  • Disruption of the npBAF to nBAF transition might contribute to conditions like autism or intellectual disability

  • Abnormal PHF10 persistence could impair proper neuronal differentiation and circuit formation

• Neurodegenerative diseases:

  • Chromatin remodeling defects are increasingly linked to neurodegeneration

  • PHF10's role in regulating gene expression may provide insights into pathological mechanisms

• Brain tumors:

  • As a regulator of neural progenitor proliferation, PHF10 dysregulation could contribute to brain tumor formation

  • The BAF complex components are frequently mutated in cancers, suggesting PHF10 as a potential research target

• Therapeutic implications:

  • Understanding PHF10 function could identify novel targets for intervention

  • Modulating chromatin remodeling through PHF10-related pathways might offer therapeutic opportunities

Research examining PHF10 expression in patient samples or disease models should include comprehensive controls and validate findings using multiple methodological approaches .

How can single-cell approaches enhance PHF10 functional studies?

Single-cell technologies offer powerful approaches for PHF10 research:

• scRNA-seq applications:

  • Track PHF10 expression dynamics across diverse cell populations during development

  • Correlate PHF10 expression with transcriptome-wide changes during differentiation

  • Identify cell subpopulations with distinct PHF10 expression patterns

• scATAC-seq integration:

  • Map chromatin accessibility changes associated with PHF10 activity

  • Correlate PHF10 expression with genome-wide chromatin state changes

  • Identify regulatory elements potentially targeted by PHF10-containing complexes

• Methodological considerations:

  • Use PHF10 antibodies for cell sorting prior to single-cell analysis

  • Combine with lineage tracing to track progeny of PHF10-expressing cells

  • Apply multimodal approaches (protein + RNA) to correlate PHF10 protein levels with transcriptional output

What approaches can determine PHF10 interactions with histone modifications?

To investigate PHF10 interactions with histone modifications:

• Biochemical approaches:

  • Perform peptide pulldown assays using modified histone peptides

  • Use recombinant PHF10 in histone modification binding arrays

  • Conduct domain-specific mutagenesis to identify key residues involved in histone binding

• Cell-based methods:

  • Implement sequential ChIP (re-ChIP) to identify co-occurrence of PHF10 and specific histone marks

  • Use proximity ligation assays to detect PHF10-histone modification interactions in situ

  • Apply FRET-based approaches with tagged PHF10 and histone modification-specific antibodies

• Analytical strategies:

  • Correlate ChIP-seq profiles of PHF10 with various histone modifications

  • Analyze the impact of histone modification inhibitors on PHF10 genomic localization

  • Examine PHF10 recruitment dynamics following induced changes in histone modification states

For these experiments, use highly specific antibodies against both PHF10 and the histone modifications of interest, with appropriate controls to validate interaction specificity.